Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lung Diseases × lorlatinib × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 24 Lung Neoplasms 5 Recurrence 3 Non Small Cell Lung Cancer Metastatic 3 Neuroblastoma 3 Neoplasm Metastasis 3 Neoplasms 2 Meningeal Carcinomatosis 2 Brain Neoplasms 2 Advanced Non-Small Cell Lung Cancer 2 Thrombocytosis 1 Sexual Dysfunction, Physiological 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Non Small Cell Lung Cancer ALK Positive or ROS1 Positive 1 Neurofibromatosis 1 1 Neoadjuvant Non-Small Cell Lung Cancer 1 NSCLC 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large-Cell, Anaplastic 1 Lung Diseases 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1

Interventions

Carboplatin 16 Pemetrexed 8 Paclitaxel 6 pembrolizumab 5 Cisplatin 5 Nivolumab 4 osimertinib 3 entinostat 3 atezolizumab 3 Erlotinib Hydrochloride 3 zipalertinib 2 selpercatinib 2 pralsetinib 2 durvalumab 2 camrelizumab 2 apatinib 2 One-Lung Ventilation 2 Ipilimumab 2 Bronchoscopy 2 Blood Specimen Collection 2 Bevacizumab 2 130-nm albumin-bound paclitaxel 2 zimberelimab 1 toripalimab 1 taletrectinib 1 spartalizumab 1 sotorasib 1 sitravatinib 1 sintilimab 1 sacituzumab govitecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05167500 2023-03-30

LORLAPULM

Fundación GECP

Carcinoma, Non-Small-Cell Lung, Lung Diseases, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡